{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:36:09Z","timestamp":1777581369816,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"15-16","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00508-021-01820-3","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T15:04:25Z","timestamp":1616511865000},"page":"750-761","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["2020 update of the Austrian Society of Cardiology (\u00d6KG) and the Austrian Society of Cardiac Surgery (\u00d6GHTG) on the position statement of the \u00d6KG and \u00d6GHTG for transcatheter aortic valve implantation 2011"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0628-7028","authenticated-orcid":false,"given":"Gudrun","family":"Lamm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Hammerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uta C.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Andreas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald K.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Bonaros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Delle-Karth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Frick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Grund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Metzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Neunteufl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albrecht","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfried","family":"Wisser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Zierer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainald","family":"Seitelberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Geppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"\u00d6KG and \u00d6GHTG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"key":"1820_CR1","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner\u00a0H, Falk\u00a0V, Bax\u00a0JJ, De Bonis\u00a0M, Hamm\u00a0C, Holm\u00a0PJ, et\u00a0al. 2017 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart\u00a0J. 2017;38:2739\u201391.","journal-title":"Eur Heart J"},{"key":"1820_CR2","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","volume":"374","author":"MB Leon","year":"2016","unstructured":"Leon\u00a0MB, Smith\u00a0CR, Mack\u00a0MJ, Makkar\u00a0RR, Svensson\u00a0LG, Kodali\u00a0SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N\u00a0Engl J Med. 2016;374:1609\u201320.","journal-title":"N Engl J Med"},{"key":"1820_CR3","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","volume":"376","author":"MJ Reardon","year":"2017","unstructured":"Reardon\u00a0MJ, Van Mieghem\u00a0NM, Popma\u00a0JJ, Kleiman\u00a0NS, Sondergaard\u00a0L, Mumtaz\u00a0M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N\u00a0Engl J Med. 2017;376:1321\u201331.","journal-title":"N Engl J Med"},{"key":"1820_CR4","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/S0140-6736(16)30073-3","volume":"387","author":"VH Thourani","year":"2016","unstructured":"Thourani\u00a0VH, Kodali\u00a0S, Makkar\u00a0RR, Herrmann\u00a0HC, Williams\u00a0M, Babaliaros\u00a0V, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a\u00a0propensity score analysis. Lancet. 2016;387:2218\u201325.","journal-title":"Lancet"},{"key":"1820_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1910555","volume":"382","author":"RR Makkar","year":"2020","unstructured":"Makkar\u00a0RR, Thourani\u00a0VH, Mack\u00a0MJ, Kodali\u00a0SK, Kapadia\u00a0S, Webb\u00a0JG, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N\u00a0Engl J Med. 2020;382:799\u2013809.","journal-title":"N Engl J Med"},{"issue":"18","key":"1820_CR6","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","volume":"380","author":"MJ Mack","year":"2019","unstructured":"Mack\u00a0MJ, Leon\u00a0MB, Thourani\u00a0VH, Makkar\u00a0R, Kodali\u00a0SK, Russo\u00a0M, et al. Transcatheter aortic-valve replacement with a\u00a0balloon-expandable valve in low-risk patients. N\u00a0Engl J Med. 2019;380(18):1695\u2013705.","journal-title":"N Engl J Med"},{"issue":"18","key":"1820_CR7","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","volume":"380","author":"JJ Popma","year":"2019","unstructured":"Popma\u00a0JJ, Deeb\u00a0GM, Yakubov\u00a0SJ, Mumtaz\u00a0M, Gada\u00a0H, O\u2019Hair\u00a0D, et al. Transcatheter aortic-valve replacement with a\u00a0self-expanding valve in low-risk patients. N\u00a0Engl J Med. 2019;380(18):1706\u201315.","journal-title":"N Engl J Med"},{"key":"1820_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2016.03.007","volume":"31","author":"E Dent","year":"2016","unstructured":"Dent\u00a0E, Kowal\u00a0P, Hoogendijk\u00a0EO. Frailty measurement in research and clinical practice: a review. Eur J Intern Med. 2016;31:3\u201310.","journal-title":"Eur J Intern Med"},{"key":"1820_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jacc.2013.08.1641","volume":"63","author":"RR Makkar","year":"2014","unstructured":"Makkar\u00a0RR, Jilaihawi\u00a0H, Mack\u00a0M, Chakravarty\u00a0T, Cohen\u00a0DJ, Cheng\u00a0W, et\u00a0al. Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons. J\u00a0Am Coll Cardiol. 2014;63:901\u201311.","journal-title":"J. Am. Coll. Cardiol."},{"key":"1820_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJM199907153410302","volume":"341","author":"CM Otto","year":"1999","unstructured":"Otto\u00a0CM, Lind\u00a0BK, Kitzman\u00a0DW, Gersh\u00a0BJ, Siscovick\u00a0DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N\u00a0Engl J Med. 1999;341:142\u20137.","journal-title":"N Engl J Med"},{"key":"1820_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jacc.2012.10.049","volume":"61","author":"JM Beach","year":"2013","unstructured":"Beach\u00a0JM, Mihaljevic\u00a0T, Svensson\u00a0LG, Rajeswaran\u00a0J, Marwick\u00a0T, Griffin\u00a0B, et\u00a0al. Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis. J\u00a0Am Coll Cardiol. 2013;61:837\u201348.","journal-title":"J. Am. Coll. Cardiol."},{"key":"1820_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0022-5223(19)35758-7","volume":"95","author":"LS Czer","year":"1988","unstructured":"Czer\u00a0LS, Gray\u00a0RJ, Stewart\u00a0ME, De Robertis\u00a0M, Chaux\u00a0A, Matloff\u00a0JM. Reduction in sudden late death by concomitant revascularization with aortic valve replacement. J\u00a0Thorac Cardiovasc Surg. 1988;95:390\u2013401.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1820_CR13","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1161\/CIRCULATIONAHA.111.039180","volume":"125","author":"SS Goel","year":"2012","unstructured":"Goel\u00a0SS, Agarwal\u00a0S, Tuzcu\u00a0EM, Ellis\u00a0SG, Svensson\u00a0LG, Zaman\u00a0T, et\u00a0al. Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacement. Circulation. 2012;125:1005\u201313.","journal-title":"Circulation"},{"key":"1820_CR14","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","volume":"363","author":"MB Leon","year":"2010","unstructured":"Leon\u00a0MB, Smith\u00a0CR, Mack\u00a0M, Miller\u00a0DC, Moses\u00a0JW, Svensson\u00a0LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N\u00a0Engl J Med. 2010;363:1597\u2013607.","journal-title":"N Engl J Med"},{"key":"1820_CR15","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","volume":"364","author":"CR Smith","year":"2011","unstructured":"Smith\u00a0CR, Leon\u00a0MB, Mack\u00a0MJ, Miller\u00a0DC, Moses\u00a0JW, Svensson\u00a0LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N\u00a0Engl J Med. 2011;364:2187\u201398.","journal-title":"N Engl J Med"},{"key":"1820_CR16","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa1114705","volume":"366","author":"M Gilard","year":"2012","unstructured":"Gilard\u00a0M, Eltchaninoff\u00a0H, Iung\u00a0B, Donzeau-Gouge\u00a0P, Chevreul\u00a0K, Fajadet\u00a0J, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N\u00a0Engl J Med. 2012;366:1705\u201315.","journal-title":"N Engl J Med"},{"key":"1820_CR17","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.jacc.2014.02.573","volume":"63","author":"L Nombela-Franco","year":"2014","unstructured":"Nombela-Franco\u00a0L, Ribeiro\u00a0HB, Urena\u00a0M, Allende\u00a0R, Amat-Santos\u00a0I, DeLarochelliere\u00a0R, et al. Significant mitral regurgitation left untreated at the time of aortic valve replacement: a\u00a0comprehensive review of a\u00a0frequent entity in the transcatheter aortic valve replacement era. J Am Coll Cardiol. 2014;63:2643\u201358.","journal-title":"J. Am. Coll. Cardiol."},{"key":"1820_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.amjcard.2013.03.024","volume":"112","author":"R Zahn","year":"2013","unstructured":"Zahn\u00a0R, Gerckens\u00a0U, Linke\u00a0A, Sievert\u00a0H, Kahlert\u00a0P, Hambrecht\u00a0R, et al. Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol. 2013;112:272\u20139.","journal-title":"Am J Cardiol"},{"key":"1820_CR19","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.amjcard.2015.01.022","volume":"115","author":"T Chakravarty","year":"2015","unstructured":"Chakravarty\u00a0T, Van Belle\u00a0E, Jilaihawi\u00a0H, Noheria\u00a0A, Testa\u00a0L, Bedogni\u00a0F, et al. Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation. Am J Cardiol. 2015;115:942\u20139.","journal-title":"Am J Cardiol"},{"key":"1820_CR20","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jtcvs.2018.10.146","volume":"158","author":"R Diaz","year":"2019","unstructured":"Diaz\u00a0R, Hernandez-Vaquero\u00a0D, Alvarez-Cabo\u00a0R, Avanzas\u00a0P, Silva\u00a0J, Moris\u00a0C, et al. Long-term outcomes of mechanical versus biological aortic valve prosthesis: systematic review and meta-analysis. J\u00a0Thorac Cardiovasc Surg. 2019;158:706\u2013714.e18.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1820_CR21","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.jacc.2018.03.535","volume":"71","author":"JD Puskas","year":"2018","unstructured":"Puskas\u00a0JD, Gerdisch\u00a0M, Nichols\u00a0D, Fermin\u00a0L, Rhenman\u00a0B, Kapoor\u00a0D, et al. Anticoagulation and antiplatelet strategies after on\u2011X mechanical aortic valve replacement. J Am Coll Cardiol. 2018;71:2717\u201326.","journal-title":"J. Am. Coll. Cardiol."},{"key":"1820_CR22","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.jacc.2016.03.506","volume":"67","author":"GM Deeb","year":"2016","unstructured":"Deeb\u00a0GM, Reardon\u00a0MJ, Chetcuti\u00a0S, Patel\u00a0HJ, Grossman\u00a0PM, Yakubov\u00a0SJ, et al. 3\u2011year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67:2565\u201374.","journal-title":"J. Am. Coll. Cardiol."},{"key":"1820_CR23","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","volume":"385","author":"MJ Mack","year":"2015","unstructured":"Mack\u00a0MJ, Leon\u00a0MB, Smith\u00a0CR, Miller\u00a0DC, Moses\u00a0JW, Tuzcu\u00a0EM, et al. 5\u2011year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a\u00a0randomised controlled trial. Lancet. 2015;385:2477\u201384.","journal-title":"Lancet"},{"issue":"6","key":"1820_CR24","doi-asserted-by":"publisher","first-page":"e003665","DOI":"10.1161\/CIRCINTERVENTIONS.115.003665","volume":"9","author":"L Sondergaard","year":"2016","unstructured":"Sondergaard\u00a0L, Steinbruchel\u00a0DA, Ihlemann\u00a0N, Nissen\u00a0H, Kjeldsen\u00a0BJ, Petursson\u00a0P, et al. Two-year outcomes in patients with severe aortic valve stenosis randomized to transcatheter versus surgical aortic valve replacement: the all-comers nordic aortic valve intervention randomized clinical trial. Circ Cardiovasc Interv. 2016;9(6):e3665.","journal-title":"Circ Cardiovasc Interv"},{"key":"1820_CR25","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.jacc.2015.03.014","volume":"65","author":"HG Thyregod","year":"2015","unstructured":"Thyregod\u00a0HG, Steinbruchel\u00a0DA, Ihlemann\u00a0N, Nissen\u00a0H, Kjeldsen\u00a0BJ, Petursson\u00a0P, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1\u2011year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65:2184\u201394.","journal-title":"J. Am. Coll. Cardiol."},{"key":"1820_CR26","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jacc.2018.10.083","volume":"73","author":"L Sondergaard","year":"2019","unstructured":"Sondergaard\u00a0L, Ihlemann\u00a0N, Capodanno\u00a0D, Jorgensen\u00a0TH, Nissen\u00a0H, Kjeldsen\u00a0BJ, et\u00a0al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J\u00a0Am Coll Cardiol. 2019;73:546\u201353.","journal-title":"J. Am. Coll. Cardiol."},{"key":"1820_CR27","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/S0140-6736(15)60290-2","volume":"385","author":"SR Kapadia","year":"2015","unstructured":"Kapadia\u00a0SR, Leon\u00a0MB, Makkar\u00a0RR, Tuzcu\u00a0EM, Svensson\u00a0LG, Kodali\u00a0S, et al. 5\u2011year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a\u00a0randomised controlled trial. Lancet. 2015;385:2485\u201391.","journal-title":"Lancet"},{"key":"1820_CR28","doi-asserted-by":"publisher","first-page":"i5130","DOI":"10.1136\/bmj.i5130","volume":"354","author":"RA Siemieniuk","year":"2016","unstructured":"Siemieniuk\u00a0RA, Agoritsas\u00a0T, Manja\u00a0V, Devji\u00a0T, Chang\u00a0Y, Bala\u00a0MM, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis. BMJ. 2016;354:i5130.","journal-title":"BMJ"},{"key":"1820_CR29","doi-asserted-by":"publisher","first-page":"i5085","DOI":"10.1136\/bmj.i5085","volume":"354","author":"PO Vandvik","year":"2016","unstructured":"Vandvik\u00a0PO, Otto\u00a0CM, Siemieniuk\u00a0RA, Bagur\u00a0R, Guyatt\u00a0GH, Lytvyn\u00a0L, et\u00a0al. Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a\u00a0clinical practice guideline. BMJ. 2016;354:i5085.","journal-title":"BMJ"},{"key":"1820_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jacc.2017.04.056","volume":"70","author":"JD Carroll","year":"2017","unstructured":"Carroll\u00a0JD, Vemulapalli\u00a0S, Dai\u00a0D, Matsouaka\u00a0R, Blackstone\u00a0E, Edwards\u00a0F, et\u00a0al. Procedural experience for transcatheter aortic valve replacement and relation to outcomes: the STS\/ACC TVT registry. J\u00a0Am Coll Cardiol. 2017;70:29\u201341.","journal-title":"J. Am. Coll. Cardiol."},{"key":"1820_CR31","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.jcin.2018.06.044","volume":"11","author":"AWA Wassef","year":"2018","unstructured":"Wassef\u00a0AWA, Rodes-Cabau\u00a0J, Liu\u00a0Y, Webb\u00a0JG, Barbanti\u00a0M, Munoz-Garcia\u00a0AJ, et al. The learning curve and annual procedure volume standards for optimum outcomes of transcatheter aortic valve replacement: findings from an international registry. JACC Cardiovasc Interv. 2018;11:1669\u201379.","journal-title":"JACC Cardiovasc Interv"},{"key":"1820_CR32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1901109","author":"S Vemulapalli","year":"2019","unstructured":"Vemulapalli\u00a0S, Carroll\u00a0JD, Mack\u00a0MJ, Li\u00a0Z, Dai\u00a0D, Kosinski\u00a0AS, et al. Procedural volume and outcomes for transcatheter aortic-valve replacement. N\u00a0Engl J Med. 2019; https:\/\/doi.org\/10.1056\/NEJMsa1901109.","journal-title":"N Engl J Med"},{"key":"1820_CR33","doi-asserted-by":"publisher","first-page":"914","DOI":"10.4244\/EIJ-D-17-00062","volume":"13","author":"K Bestehorn","year":"2017","unstructured":"Bestehorn\u00a0K, Eggebrecht\u00a0H, Fleck\u00a0E, Bestehorn\u00a0M, Mehta\u00a0RH, Kuck\u00a0KH. Volume-outcome relationship with transfemoral transcatheter aortic valve implantation (TAVI): insights from the compulsory German quality assurance registry on aortic valve replacement (AQUA). EuroIntervention. 2017;13:914\u201320.","journal-title":"EuroIntervention"},{"key":"1820_CR34","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ccd.26266","volume":"87","author":"T Inohara","year":"2016","unstructured":"Inohara\u00a0T, Hayashida\u00a0K, Watanabe\u00a0Y, Yamamoto\u00a0M, Takagi\u00a0K, Yashima\u00a0F, et al. Streamlining the learning process for TAVI: Insight from a\u00a0comparative analysis of the OCEAN-TAVI and the massy registries. Catheter Cardiovasc Interv. 2016;87:963\u201370.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1820_CR35","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1093\/eurheartj\/ehw190","volume":"37","author":"H Eggebrecht","year":"2016","unstructured":"Eggebrecht\u00a0H, Bestehorn\u00a0M, Haude\u00a0M, Schmermund\u00a0A, Bestehorn\u00a0K, Voigtlander\u00a0T, et al. Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919\u00a0patients. Eur Heart\u00a0J. 2016;37:2240\u20138.","journal-title":"Eur Heart J"},{"key":"1820_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.15420\/icr.2015.10.1.55","volume":"10","author":"H Eggebrecht","year":"2015","unstructured":"Eggebrecht\u00a0H, Schmermund\u00a0A. The current situation and the future of emergent cardiac surgery in TAVI. Interv Cardiol. 2015;10:55\u20137.","journal-title":"Interv Cardiol"},{"key":"1820_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/CIRCINTERVENTIONS.111.967315","volume":"5","author":"M Pasic","year":"2012","unstructured":"Pasic\u00a0M, Unbehaun\u00a0A, Dreysse\u00a0S, Buz\u00a0S, Drews\u00a0T, Kukucka\u00a0M, et al. Rupture of the device landing zone during transcatheter aortic valve implantation: a\u00a0life-threatening but treatable complication. Circ Cardiovasc Interv. 2012;5:424\u201332.","journal-title":"Circ Cardiovasc Interv"},{"key":"1820_CR38","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1093\/eurheartj\/eht381","volume":"35","author":"CW Hamm","year":"2014","unstructured":"Hamm\u00a0CW, Mollmann\u00a0H, Holzhey\u00a0D, Beckmann\u00a0A, Veit\u00a0C, Figulla\u00a0HR, et al. The German aortic valve registry (GARY): in-hospital outcome. Eur Heart\u00a0J. 2014;35:1588\u201398.","journal-title":"Eur Heart J"},{"key":"1820_CR39","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/j.jcin.2018.07.015","volume":"11","author":"F Egger","year":"2018","unstructured":"Egger\u00a0F, Zweiker\u00a0D, Freynhofer\u00a0MK, Loffler\u00a0V, Rohla\u00a0M, Geppert\u00a0A, et al. Impact of on-site cardiac surgery on clinical outcomes after transfemoral transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11:2160\u20137.","journal-title":"JACC Cardiovasc Interv"},{"key":"1820_CR40","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jcin.2014.04.005","volume":"7","author":"V Babaliaros","year":"2014","unstructured":"Babaliaros\u00a0V, Devireddy\u00a0C, Lerakis\u00a0S, Leonardi\u00a0R, Iturra\u00a0SA, Mavromatis\u00a0K, et\u00a0al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv. 2014;7:898\u2013904.","journal-title":"JACC Cardiovasc Interv"},{"key":"1820_CR41","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.carrev.2017.08.002","volume":"19","author":"S Gurevich","year":"2018","unstructured":"Gurevich\u00a0S, Oestreich\u00a0B, Kelly\u00a0RF, Mbai\u00a0M, Bertog\u00a0S, Ringsred\u00a0K, et\u00a0al. Outcomes of transcatheter aortic valve replacement using a\u00a0minimalist approach. Cardiovasc Revasc Med. 2018;19:192\u20135.","journal-title":"Cardiovasc Revasc Med"},{"key":"1820_CR42","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.jcin.2018.06.043","volume":"11","author":"M Spaziano","year":"2018","unstructured":"Spaziano\u00a0M, Lefevre\u00a0T, Romano\u00a0M, Eltchaninoff\u00a0H, Leprince\u00a0P, Motreff\u00a0P, et\u00a0al. Transcatheter aortic valve replacement in the catheterization laboratory versus hybrid operating room: insights from the FRANCE TAVI registry. JACC Cardiovasc Interv. 2018;11:2195\u2013203.","journal-title":"JACC Cardiovasc Interv"},{"key":"1820_CR43","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.jcin.2018.06.023","volume":"11","author":"P Deharo","year":"2018","unstructured":"Deharo\u00a0P, Jaussaud\u00a0N, Grisoli\u00a0D, Camus\u00a0O, Resseguier\u00a0N, Le Breton\u00a0H, et\u00a0al. Impact of direct transcatheter aortic valve replacement without balloon aortic valvuloplasty on procedural and clinical outcomes: insights from the FRANCE TAVI registry. JACC Cardiovasc Interv. 2018;11:1956\u201365.","journal-title":"JACC Cardiovasc Interv"},{"key":"1820_CR44","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jcin.2016.03.024","volume":"9","author":"S Toggweiler","year":"2016","unstructured":"Toggweiler\u00a0S, Stortecky\u00a0S, Holy\u00a0E, Zuk\u00a0K, Cuculi\u00a0F, Nietlispach\u00a0F, et al. The electrocardiogram after transcatheter aortic valve replacement determines the risk for post-procedural high-degree AV block and the need for telemetry monitoring. JACC Cardiovasc Interv. 2016;9:1269\u201376.","journal-title":"JACC Cardiovasc Interv"},{"key":"1820_CR45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2017815","author":"J Brouwer","year":"2020","unstructured":"Brouwer\u00a0J, et al. Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N\u00a0Engl J Med. 2020; https:\/\/doi.org\/10.1056\/NEJMoa2017815.","journal-title":"N Engl J Med"},{"key":"1820_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00392-019-01528-5","volume":"109","author":"W von Scheidt","year":"2020","unstructured":"von Scheidt\u00a0W, et al. Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI) : joint consensus document of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhaus\u00e4rzte e.\u202fV. (ALKK) and cooperating cardiac surgery department. Clin Res Cardiol. 2020;109:1\u201312.","journal-title":"Clin Res Cardiol"},{"key":"1820_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.018","author":"C Otto","year":"2020","unstructured":"Otto\u00a0C, et\u00a0al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease:\u00a0a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. J\u00a0Am Coll Cardiol. 2020; https:\/\/doi.org\/10.1016\/j.jacc.2020.11.018.","journal-title":"J Am Coll Cardiol"},{"key":"1820_CR48","doi-asserted-by":"crossref","unstructured":"Lamm G. New strategies in the management of valvular heart disease. Wien Klin Wochenschr. 2021. (submitted)","DOI":"10.1007\/s00508-021-01879-y"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-021-01820-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-021-01820-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-021-01820-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T09:22:35Z","timestamp":1629278555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-021-01820-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":48,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1820"],"URL":"https:\/\/doi.org\/10.1007\/s00508-021-01820-3","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"6 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.\u00a0Lamm: speaker fees from Boston Scientific, Edwards Lifesciences and Medtronic, educational grants from Abbott, Edwards Lifesciences and Medtronic.M.\u00a0Andreas: proctor for Edwards Lifesciences and Abbott; advisor for Medtronic.R.K.\u00a0Binder: proctor for Boston Scientific, consultant for Edwards Lifesciences, speaker fees and educational grants from Abbott and Medtronic.N.\u00a0Bonaros: speaker fees\/consultant for Edwards Lifesciences, Abbott, Medtronic, Livanova. Educational Grants\/Research Grants from Edwards Lifesciences, Livanova.G.\u00a0Delle-Karth: speaker fees, research and educational grants from Edwards Lifesciences and Medtronic; consultant for Edwards Lifesciences and Medtronic.A.\u00a0Geppert: speaker fees from Medtronic, Abbott and Edwards; consultant for Abbott.M.\u00a0Hammerer, U.C.\u00a0Hoppe, R.\u00a0Berger, M.\u00a0Frick, M.\u00a0Grund, B.\u00a0Metzler, T.\u00a0Neunteufl, P.\u00a0Pichler, A.\u00a0Schmidt, W.\u00a0Wisser, A.\u00a0Zierer, R.\u00a0Seitelberger and M.\u00a0Grimm declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}